4EGI-1
Chemical Name: α-[2-[4-(3,4-Dichlorophenyl)-2-thiazolyl]hydrazinylidene]-2-nitro-benzenepropanoic acid
Purity: ≥98%
Biological Activity
4EGI-1 is an inhibitor of eIF4E:eIF4G interaction; prevents eIF4E binding to eIF4G. Binds eIF4E and inhibits cap-dependent translation but not initiation factor-independent translation. Exhibits activity against Jurkat and A549 cells.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Complete Your Research
Background References
-
Autism-related deficits via dysregulated eIF4E-dependent translational control.
Gkogkas C, Khoutorsky A, Ran I, Rampakakis E, Nevarko T, Weatherill D, Vasuta C, Yee S, Truitt M, Dallaire P, Major F, Lasko P, Ruggero D, Nader K, Lacaille J, Sonenberg N
Nature, 2013;493(7432):371-7. -
Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
Moerke et al.
Cell, 2007;128:257
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citation for 4EGI-1
The citations listed below are publications that use Tocris products. Selected citations for 4EGI-1 include:
1 Citation: Showing 1 - 1
-
Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming.
Authors: Riz Et al.
Oncotarget 2016;7:66360
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for 4EGI-1
There are currently no reviews for this product. Be the first to review 4EGI-1 and earn rewards!
Have you used 4EGI-1?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image